Veracyte
VCYT
231 hedge funds and large institutions have $1.96B invested in Veracyte in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 91 increasing their positions, 82 reducing their positions, and 25 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
11% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 82
1% less funds holding
Funds holding: 233 → 231 (-2)
4% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 25
2.66% less ownership
Funds ownership: 109.07% → 106.41% (-2.7%)
25% less capital inflows, than outflows
Capital inflows: $114M | Capital outflows: $152M
58% less call options, than puts
Call options by funds: $252K | Put options by funds: $593K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.1M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$12.2M |
| 3 |
BlackRock
New York
|
+$6.63M |
| 4 |
Oberweis Asset Management
Lisle,
Illinois
|
+$6.55M |
| 5 |
Morgan Stanley
New York
|
+$6.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$22.7M |
| 2 |
ARK Investment Management
St. Petersburg,
Florida
|
-$14.1M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$13.6M |
| 4 |
State Street
Boston,
Massachusetts
|
-$13.6M |
| 5 |
Granahan Investment Management
Waltham,
Massachusetts
|
-$13.4M |
VCYT Hedge Fund Activity: Q2 2023 in Review
231 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2023, worth a combined $1.96B — up 13% from $1.74B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of VCYT and 24 opened new positions — a net loss of 1 holder — while 82 trimmed existing stakes and 91 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $27.1M. The largest seller was Citadel Advisors, cutting an estimated $22.7M.
- 231 institutional investors held Veracyte (VCYT) as of Q2 2023, down from 233 in Q1 2023.
- Funds reported $1.96B of Veracyte stock for Q2 2023, up 13% quarter-over-quarter.
- 24 funds opened new Veracyte positions in Q2 2023 and 25 closed out, a net change of -1 holder.
- The largest Veracyte buyer in Q2 2023 was Point72 Asset Management, an estimated $27.1M added.
- The largest Veracyte seller in Q2 2023 was Citadel Advisors, an estimated $22.7M sold.
Based on aggregated 13F filings for Q2 2023.